Hussain A - Search Results

1

Novel approaches targeting mitochondrial fission to deplete stem-like tumor cells in prostate cancer and improve treatment outcomes.

Passaniti A, Hussain A. Passaniti A, et al. Among authors: hussain a. Ann Transl Med. 2019 Dec;7(Suppl 8):S335. doi: 10.21037/atm.2019.09.109. Ann Transl Med. 2019. PMID: 32016053 Free PMC article. No abstract available.

2

Metabolic targets for potential prostate cancer therapeutics.

Twum-Ampofo J, Fu DX, Passaniti A, Hussain A, Siddiqui MM. Twum-Ampofo J, et al. Among authors: hussain a. Curr Opin Oncol. 2016 May;28(3):241-7. doi: 10.1097/CCO.0000000000000276. Curr Opin Oncol. 2016. PMID: 26907571 Free PMC article. Review.

3

Metformin and Androgen Receptor-Axis-Targeted (ARAT) Agents Induce Two PARP-1-Dependent Cell Death Pathways in Androgen-Sensitive Human Prostate Cancer Cells.

Xie Y, Wang L, Khan MA, Hamburger AW, Guang W, Passaniti A, Munir K, Ross DD, Dean M, Hussain A. Xie Y, et al. Among authors: hussain a. Cancers (Basel). 2021 Feb 5;13(4):633. doi: 10.3390/cancers13040633. Cancers (Basel). 2021. PMID: 33562646 Free PMC article.

4

Regulators of prostate cancer stem cells.

Kerr CL, Hussain A. Kerr CL, et al. Among authors: hussain a. Curr Opin Oncol. 2014 May;26(3):328-33. doi: 10.1097/CCO.0000000000000080. Curr Opin Oncol. 2014. PMID: 24651383 Review.

5

Targeting of protein translation as a new treatment paradigm for prostate cancer.

Ramamurthy VP, Ramalingam S, Kwegyir-Afful AK, Hussain A, Njar VCO. Ramamurthy VP, et al. Among authors: hussain a. Curr Opin Oncol. 2017 May;29(3):210-220. doi: 10.1097/CCO.0000000000000367. Curr Opin Oncol. 2017. PMID: 28282343 Free PMC article.

6

Targeting androgen biosynthesis in prostate cancer: implications on endocrine physiology.

Kango G, Malek R, Mannuel H, Hussain A. Kango G, et al. Among authors: hussain a. Curr Opin Oncol. 2024 May 1;36(3):195-201. doi: 10.1097/CCO.0000000000001032. Epub 2024 Feb 26. Curr Opin Oncol. 2024. PMID: 38573209 Review.

7

Thapsigargin resistance in human prostate cancer cells.

O'Neill JP, Velalar CN, Lee DI, Zhang B, Nakanishi T, Tang Y, Selaru F, Ross D, Meltzer SJ, Hussain A. O'Neill JP, et al. Among authors: hussain a. Cancer. 2006 Aug 1;107(3):649-59. doi: 10.1002/cncr.22027. Cancer. 2006. PMID: 16770788 Free article.

8

Telomere and microtubule targeting in treatment-sensitive and treatment-resistant human prostate cancer cells.

Zhang B, Suer S, Livak F, Adediran S, Vemula A, Khan MA, Ning Y, Hussain A. Zhang B, et al. Among authors: hussain a. Mol Pharmacol. 2012 Aug;82(2):310-21. doi: 10.1124/mol.111.076752. Epub 2012 May 14. Mol Pharmacol. 2012. PMID: 22584221

9

Understanding heterogeneity of treatment effect in prostate cancer.

Aly A, Mullins CD, Hussain A. Aly A, et al. Among authors: hussain a. Curr Opin Oncol. 2015 May;27(3):209-16. doi: 10.1097/CCO.0000000000000172. Curr Opin Oncol. 2015. PMID: 25689354 Review.

10

Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.

Zhang Y, Lapidus RG, Liu P, Choi EY, Adediran S, Hussain A, Wang X, Liu X, Dan HC. Zhang Y, et al. Among authors: hussain a. Mol Cancer Ther. 2016 Jul;15(7):1504-14. doi: 10.1158/1535-7163.MCT-15-0999. Epub 2016 Apr 8. Mol Cancer Ther. 2016. PMID: 27196761 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,372 results

Search Page